chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experienced slight heaviness and then a tingling parasthesia in the feet that traveled up to my knees. I stayed for one hour, it began to feel like a cold sensation. I was able to walk and did not f; I experienced slight heaviness and then a tingling parasthesia in the feet that traveled up to my knees. I stayed for one hour, it began to feel like a cold sensation. I was able to walk and did not f; I experienced slight heaviness and then a tingling parasthesia in the feet that traveled up to my knees. I stayed for one hour, it began to feel like a cold sensation. I was able to walk and did not f; anxiety; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), intramuscularly on 15Dec2020 07:45 at single dose for covid-19 immunization. Vaccine location was left arm and it was the first dose. None medical history. No known allergies. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. There were no concomitant medications. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine nor received any other medications within 2 weeks of vaccination. At 22Dec2020 07:45 am, the patient experienced slight heaviness and then a tingling parasthesia in the feet that traveled up to her knees. She stayed for one hour, it began to feel like a cold sensation. She was able to walk and did not feel dizzy and left work. The patient reported them to the MD who said it could be a coincidence and anxiety. Patient didn't receive any treatment for the adverse events. The action taken in response to the events for BNT162B2 was not applicable. The outcome of events was unknown. The events were non-serious.
On 03/19/2021 I got diareahha real bad everyday till July.  My right arm starting acting funny.  On May 15th while folding towels my right arm just started levitating  by itself and my fingers curled up.  I was taken to the hospital on the 15th and CT Scan and a brain tumor was discovered, the tumor removal was on May 26th.  The tumor was cancer. Currently undergoing cancer treatments.
Two blood blisters on inside of left cheek; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 20Apr2021 at 15:45 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included paracetamol (TYLENOL) for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8734) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. On 22Apr2021 at 12:15, the patient experienced two blood blisters on inside of left cheek which were not painful. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event two blood blisters on inside of left cheek was unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Pt recv vax on 9/29/98; on 2/18/99 pt exp shingles herpes zoster (blistering red rash)
Information has been received from a registered nurse concerning a 9 year old male with no pertinent medical history or drug allergies who on 14-SEP-2007 was vaccinated with his second 0.5ml SC dose of varicella virus vaccine live (Oka/Merck) (lot# 658373/1116U). There was no concomitant medication. On that same day while the patient was in the physician's office, the patient developed a red, warm, raised, swollen area at the injection site. No lab diagnostic studies were performed. The symptoms improved before the patient left the office and the patient was noted to be recovering. There was no product quality complaint. This is one of several reports from the same source. Additional information has been requested.
Fever w/"flu-like" sx p/2nd dose of pre-exposure series; withheld 3rd dose & will do antibody titer;
BP 115/64 (BP Location: RA-RIGHT ARM, BP Patient Position: LYING, Cuff Size: Standard Adult)  | Pulse 52  | Resp 16  | SpO2 100%     Location of event Vaccine Center    Description of Event: Pt reported not feeling ok. Was sitting in chair and began to slump back into chair. Reports having blacked out for a moment.    Interventions: Transferred to gurney, given water, juice, assessed, vitals taken.    Medications administered: None   Response to interventions and/or medications given: Improvement to baseline   Disposition:Home Treatment
Chills/rigors; back ache; headache; temp was now 101.2; feeling really ill; This is a spontaneous report from a non-contactable consumer.  A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient was feeling really ill from his second vaccine shot, on 09Jan2021, he experienced chills for 12 hours, rigors, back ache, headache. First dose was only arm soreness. It was reported temp was now 101.2 (unit not provided). The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected. Information about Lot/Batch number cannot be obtained.
Trihibit erroneously given to patient under 15 months of age.  No reaction noted by phsyician or parents.  CDC contacted to learn appropriate future vaccine series to be given.  Patient to come 5/4 to repeat Hib #1.
On 9/28/99, fever 103 for 1 day only. Rash on 10/1/99, Neck red, back, neck, butt rash, looks like sunburn, not bumpy much. 10/11/99, f/u, left message to call PHD w/info re:pt's fever & rash outcome. 11/22/99, no contact from MD.
COVID 19 Treatment; COVID 19 Treatment; Pfizer / BioNTech: Dose Number: 3; Moderna Dose Number: 2, Moderna Dose Number: 1; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 27Nov2021 as dose 3 (booster), single (Lot number: FH8030) at the age of 54 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 26Mar2021 as dose 1, single (Batch/Lot number: unknown) and on 26Apr2021 as dose 2, single (Lot number: 001C21A) for covid-19 immunisation. The patient's relevant medical history included: "A fib" (unspecified if ongoing). No known allergies. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 27Nov2021, outcome "unknown", described as "Pfizer / BioNTech: Dose Number: 3; Moderna Dose Number: 2, Moderna Dose Number: 1"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Mar2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 includes Paxlovid (COVID 19 Treatment) from 20Mar2023 to 24Mar2023.
unplanned dose of Tdap given with HPV when Mening ACWY and HPV were to be given together. Mother was contacted by RN on 8/30/2023 at 09:50 and explained unplanned Tdap was given. Mother said child was a little sore, but had no other complaints. Mother was informed that Mening ACWY could be scheduled at her convenience and also made aware of due dates for next vaccines and referred to the Immunization Registry.
5cm X 3cm area of redness note at the varicella site on the left arm. Mom gave Benadryl and applied cold compresses and came into office for eval.
Headache, localized redness, swelling, hardening of area. Aches-muscles, nausea, fever.
Patient received his first dose of Moderna vaccine and reported feeling his heart rate go up around 20 minutes later. He alerted the nurse, who checked his vital signs, which were slightly elevated with a minor elevation in heart rate at 106. He denied dizziness, chest pain, extremity numbness/tingling, and any other signs. He continued to feel palpitations for about 30 minutes, but HR continued within normal limits < 100 during that time. After about a half an hour he began to feel better, and was assisted to his car by county staff.  EMS offered and declined.
All-body hives; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 20May2021 at 16:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to lamb and exposure to UV light for hours. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28May2021, the patient experienced all-body hives which was occurred 8 days after the first shot, but almost went away after 1-2 days. Therapeutic measures were taken as a result of the adverse events and included treatment with ZYRTEC. The adverse event resulted in a visit to the emergency room/department or urgent care. Since the vaccination, the patient had not tested for COVID-19.  The clinical outcome of the event all-body hives was recovering at the time of this report.    The lot number for BNT162b2 was not provided and will be requested during follow up.
On 4/2/21 during the night I experienced  and expected to have an extremely sore arm and a headache also chills Tylenol was taken. Throughout the night I felt joint body aches. I experienced fatigue On 4/3/21 when I woke up, I experienced sensitivity to light for approx. 3 hours and felt light-headed I have experienced being  light-headed for 4 days now.  I'm feeling nauseated
fainted a few seconds after injection. mother stayed with him. recovered after a few seconds was nausous. gave water. ems came. said his pressure was low . they took him away for precaution. was alert and coherent when he left.
Sore arm started within hours of vaccination.  Pain continued at the injection site and towards back of deltoid muscle rotating around upper arm, stopping approx 1 inch from underarm crease.    Pain is achy in nature and worse with motion that has now persisted for 3 weeks.  Pain is 2/5 on scale of 0/5.
received a dose / Shingrix on 03May2021 / expired on 30Nov2020; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 55-year-old female patient who received Herpes zoster (Shingrix) (batch number G72ZD, expiry date 30th November 2020) for prophylaxis.   On 3rd May 2021, the patient received the 1st dose of Shingrix. On 3rd May 2021, unknown after receiving Shingrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The office manager reported that on 3 May 2021, the patient received a dose of Shingrix which was already expired on 30 November 2020. No symptoms were reported.  The reporter consented to follow up. No additional information was available. ; Sender's Comments:  US-GLAXOSMITHKLINE-US2021099711:same reporter
On 8/25 Patient was administered both Fluzone HD and Pneumovax 23 on left arm. On 8/26 she called to let us know her left arm was swollen. She was advised to contact her Dr. She saw her primary Dr. who told her the injection sites were infected. She was prescribed an antibiotic and ibuprofen. She called us 8/28 to inform us about the infection.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 17-OCT-2012 14:00, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not provided. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0395AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Tingling and numbing thigh and calf of both legs.  Symptoms began 2 days after vaccinated
Pt reports she received J&J vaccine on 4/10 (DID NOT STATE WHERE- WAS NOT DONE AT OUR FACILITY).  Almost immediately after developed migraine headache and fever, which has slowly dissipated but has now been replaced by fatigue, chest tightness and cough.  Pt denies SOB or congestion, just feels tight. Patient also feels lightheaded and dizzy upon standing and headache increases at times. Pt advised on evaluation at urgent care.
Headache; diarrhea; chills; sweating; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 27-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot/batch no: unknown), via an unspecified route of administration, in his left arm on 17Mar2021 (at the age of 27-years-old) for COVID-19 immunisation. The patient had no medical history and had no known allergies. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine and was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The concomitant medications included cephalexin (MANUFACTURER UNKNOWN) for an unknown indication. On 18Mar2021 at 03:15 am, the patient experienced headache, diarrhea, chills, sweating and sore arm. No therapeutic measures were taken for these events. The clinical outcome of the events headache, diarrhea, chills, sweating and sore arm was unknown at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age.  No information was provided regarding concurrent conditions, medical history, or concomitant medications. On or about 10-JAN-2012, a healthcare provider at a federal health care center administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). On or about 11-DEC-2016, the patient was treated by healthcare provider at a community healthcare facility for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries.  As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
p/vax pt exp chickenpox w/approx 10 lesions w/in a 1x1 inch section;reporter noted that would contact MD office & provide f/u data;
The next day I felt like I had COVID-19 (was dx last year and very sick for several weeks); coughing, sob, fever, chills, body aches, fatigue, chest pain/pressure. Symptoms subsided within 12 hours, treated at home otc symptomatic care. Did experience only a few hours of left arm, shoulder and hand pain which was only present with the above symptoms.  Last night (4/3/21, 6 days post vaccine) my left arm, shoulder,  and hand began a very strong ache,  near bedtime. An hour, or less later, I awoke with increased pain accompanied with left sided chest pain and sob. Treated at onset and 6 hours later with no relief, but increase in symptoms. Seen at the ED early 4/4/21 for chest pain and left arm pain. Thorough work up mostly negative with exception of elevated d-dimer levels as well as enlarged axillary nodes. Continue to have left sided chest and left arm pain, but a little less severe than arrival or DC from ED.
Swollen under left arm pit area and pec. Roughly 48hrs after booster; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 16 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 23Jan2022 12:00 (Batch/Lot number: unknown) at the age of 16 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 2, single , Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 immunisation; Bnt162b2 (Dose 1, single , Batch/Lot No: Unknown. Not available/provided to reporter at the time of report completion), for COVID-19 immunisation. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 24Jan2022 12:00, outcome "recovering", described as "Swollen under left arm pit area and pec. Roughly 48hrs after booster". It was unknown if therapeutic measures were taken as a result of lymphadenopathy.  Additional information: The patient did not receive other vaccine in four weeks and did not receive other medications in two weeks prior COVID vaccination. Facility type vaccine was unknown. Covid prior vaccination and covid tested post vaccination reported as no. known allergies reported as unknown.  The lot number for bnt162b2 was not provided and will be requested during follow up.
A minute after the shot I got a really bad headache, similar to a migraine. It lasted for the full 15 minutes of my waiting time but had started to let up after that. I was given an ice water to hold to my head and drink.  The next day my arm was very swollen and sore. It hurt to touch. The swelling was still present the day after that but it had started to go down and not hurt as much when pressure was applied.  A week after the vaccine to the day my arm swelled again even more than before. There is pain if I put pressure on it but mostly it is very hard and a bit itchy. The rash is about 6 inches in length and about 7 across. When I looked up symptoms, this seemed to perfectly match the description of "COVID arm".
Fever of 102.5; chills; body aches; headache; fatigue; nausea; lightheaded; Dose received: 3; Dose received: 3; This is a spontaneous report from a contactable other Health Care Professional (patient). A 39-year-old non-pregnant female patient received third booster dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: FF2590, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 04Oct2021 17:30 (at the age of 39 years old) as dose 3 (booster), single for COVID-19 immunization. Medical history included colitis ulcerative and gastrooesophageal reflux disease. The patient was allergic to Penicillin and sulfa. Concomitant medication(s) included: Other vaccine 4weeks details was diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) on 16Sep2021 as dose 1 in left deltoid. Historical vaccine included: first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL3248, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 13Jan2021 07:30 (at the age of 38 years old) as dose 1, single and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EL9264, Expiry date: not reported) via an unspecified route of administration, administered in left arm on 01Feb2021 07:30 (at the age of 39 years old) for COVID-19 immunization. The patient was non-pregnant at the time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was tested for COVID post vaccination. On 05Oct2021 14:00, the patient experienced fever of 102.5, chills, body aches, headache, fatigue, nausea, lightheaded. The patient did not receive any treatment for the events. The patient underwent lab tests and procedures which included body temperature: 102.5 on 05Oct2021, sars-cov-2 test: negative on 06Oct2021 Nasal Swab. The outcome of the events was recovered on unspecified date in 2021.   Follow-up attempts are completed. No further information is expected.
Information has been received from a certified medical assistant (CMA) and a physician concerning a 10 week old male twin who on 16-JAN-2008 was vaccinated po with the first 2.0 ml dose of ROTATEQ ( lot#65788/1193U). Concomitant vaccines included PEDIARIX, PREVNAR and ACTHIB. It was reported that on 22-JAN-2008 the patient experienced vomiting, it continued and was seen in the office on 25-Jan-2008 with some projectile vomiting and belly pain. Patient was seen in the office on 29-JAN-2008 with less appetite, increased sleeping and still spitting up. On 31-JAN-2008 patient was still vomiting, very fussy and afebrile. Intussusception was ruled out and vomiting and fussiness resolved. On 18-FEB-2008, the patient was seen in the office for congestion and was diagnosed with bronchiolitis, wet cough and wheezing. Patient was seen again on 19-FEB-2008, 21-FEB-2008 and 22-FEB-2008 in the office for the bronchiolitis. On 23-FEB-2008, the patient was reported to be doing better. On 25-FEB-2008 the patient was seen in the emergency room with bronchiolitis (was not admitted to the hospital). Allergy tests were negative and the patient was diagnosed with intermittent wheezing. The patient was placed on therapy with FLOVENT and albuterol prn. On 19-Mar-2008 patient was seen in the office and was reported as doing "great" and physician opted not to give the ROTATEQ. The outcome is reported as recovered. This is one of several reports from the same source. No additional information is expected.
A healthcare professional reported that the patient developed swelling and a rash. The reporter indicated that 3 patients experienced this event; however, they are not presently identifiable. This is 1 of 2 reports from this facility of adverse events following receipt of Acel-Imune lot 464-307. Follow up states "Cancelled: Duplicate of #Q8380311JUL2000.